MedTrace Logo

Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer

NCT02781259 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-09-20

No results posted yet for this study

Summary

In this study, navigation of lymphatic passage after sentinel lymph node with indocyanine green was performed during axillary lymph node dissection in breast surgery . By comparing the concordance between the passage of indocyanine green and actual lymph node metastasis, selective lymph node dissection can be developed.

Conditions

  • Breast Neoplasms

Interventions

PROCEDURE

Axillary lymph node dissection

Lymph node dissection is performed in axillary lymph node level I and II. In case of palpable nodes in level II, additional lymph node dissection in level III is done.

DRUG

Indocyanine green

10cc of 20μg/mL indocyanine green is injected at the nipple-areola complex before surgery

DEVICE

Imaging devices

Near-infrared fluorescence is collected by imaging lenses and digital camera.

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • SeokWon Kim, MD. PhD. · Samsung Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-02-28
Completion
2017-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02781259 on ClinicalTrials.gov